Galera therapeutics to present at the oppenheimer 31st annual healthcare conference

Malvern, pa., march 10, 2021 (globe newswire) -- galera therapeutics, inc. (nasdaq: grtx), a clinical-stage biopharmaceutical company focused on developing and commercializing a pipeline of novel, proprietary therapeutics that have the potential to transform radiotherapy in cancer, today announced that mel sorensen, m.d., president and chief executive officer, will present at the oppenheimer 31st annual healthcare conference on wednesday, march 17, 2021, at 1:50 p.m. et.
GRTX Ratings Summary
GRTX Quant Ranking